Cognitive Resilience in Apolipoprotein ε4 Carrier Women Predicted by Neuron‐Derived Extracellular Vesicles
Annals of Clinical and Translational Neurology · 2025
DOI: 10.1002/acn3.70143 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, 2025. Verfasst von Apostolos Manolopoulos und 17 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Clinical Investigation, Intramural Research Program, National Institute on Aging, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Apolipoprotein E4, Extracellular Vesicles, Neurons, Alzheimer Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIA NIH HHS, Wyeth Pharmaceuticals.
Abstract (Originalsprache)
Objective
The Apolipoprotein ( APOE ) ε4 allele is the strongest genetic risk factor for late‐onset Alzheimer's disease (AD); however, many ε4 carriers remain cognitively intact into old age. Leveraging plasma neuron‐derived extracellular vesicles (NDEVs), we sought to identify biomarkers of cognitive resilience and their interplay with APOE genotype.
Methods
In this case‐control study nested within the Women's Health Initiative (WHI), we analyzed 1130 plasma samples from 676 women in the WHI Memory Study (WHIMS)/Long Life Study (LLS), with APOE ε4 or ε3/ε3 genotypes. At baseline, all participants were cognitively intact and at LLS visit, 13–17 years later, were classified as still cognitively intact (resilient) or having become impaired at age > 80 or ≤ 80 years. We isolated NDEVs using immunoaffinity capture for the neuronal marker L1CAM and quantified AD pathogenic proteins (Aβ 42 , total Tau, p181‐Tau), insulin signaling (pSer312‐IRS‐1), TNFR1/NFκB pathway mediators and targets, and mitochondrial Complex V. Linear mixed models assessed group differences, adjusting for NDEV yield, age, and education, with FDR correction.
Results
No group differences were found for Aβ 42 , Tau proteins, or pS312‐IRS‐1. Resilient ε4 carriers had higher baseline levels of phosphorylated TNFR1, NFκB, c‐Myc, and FADD than ε4 carriers who eventually developed impairment at > 80 or ≤ 80 years. Additionally, resilient ε4 carriers had higher baseline Complex V levels than ε4 carriers impaired at age > 80.
Interpretation
Augmented neuronal TNFR1/NFκB signaling and Complex V levels may promote cognitive resilience in ε4 carrier women. Boosting these mechanisms may have preventive and therapeutic potential against cognitive decline in this high‐risk population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Clinical Investigation, Intramural Research Program, National Institute on Aging, Baltimore, Maryland, USA.
- Department of Psychiatry and Behavioral Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
- Herbert Wertheim School of Public Health and Human Longevity Science and Division of Geriatrics, Gerontology and Palliative Care, Department of Medicine, University of California San Diego, La Jolla, California, USA.
- Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Department of Biostatistics and Data Sciences, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA.
- Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, Iowa, USA.
ORCID-Profile: Apostolos Manolopoulos
Förderung
- NHLBI NIH HHS
- NIA NIH HHS
- Wyeth Pharmaceuticals
- WHI NIH HHS
- GlaxoSmithKline Consumer Healthcare
- NIEHS NIH HHS
- Intramural Research Program of the National Institute on Aging, National Institutes of Health
- National Heart, Lung, and Blood Institute
Zitieren
APA
Manolopoulos, A., Mustapic, M., Nogueras-Ortiz, C., Delgado-Peraza, F., Pucha, K. A., Yao, P. J., Blommer, J., Vreones, M. P., York, W., Knight, D. L., Rapp, S. R., Shadyab, A. H., Manson, J. E., Casanova, R., Wallace, R. B., Ferrucci, L., Resnick, S. M., & Kapogiannis, D. (2025). Cognitive Resilience in Apolipoprotein ε4 Carrier Women Predicted by Neuron‐Derived Extracellular Vesicles. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.70143
Vancouver
Manolopoulos A, Mustapic M, Nogueras-Ortiz C, Delgado-Peraza F, Pucha KA, Yao PJ, et al. Cognitive Resilience in Apolipoprotein ε4 Carrier Women Predicted by Neuron‐Derived Extracellular Vesicles. Annals of Clinical and Translational Neurology. 2025. doi:10.1002/acn3.70143
BibTeX
@article{Manolopoulos2025,
author = {Manolopoulos, Apostolos and Mustapic, Maja and Nogueras-Ortiz, Carlos and Delgado-Peraza, Francheska and Pucha, Krishna A and Yao, Pamela J and Blommer, Joseph and Vreones, Michael P and York, William and Knight, De' Larrian and Rapp, Stephen R and Shadyab, Aladdin H and Manson, JoAnn E and Casanova, Ramon and Wallace, Robert B and Ferrucci, Luigi and Resnick, Susan M and Kapogiannis, Dimitrios},
title = {Cognitive Resilience in Apolipoprotein ε4 Carrier Women Predicted by Neuron‐Derived Extracellular Vesicles},
journal = {Annals of Clinical and Translational Neurology},
year = {2025},
doi = {10.1002/acn3.70143}
}
EUVIMED